{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:05:28Z","timestamp":1785557128575,"version":"3.56.0"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T00:00:00Z","timestamp":1339027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Thromboxane levels are increased in rats fed ethanol (<jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>t<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>), whereas thromboxane inhibitors reduce alcoholic liver injury. The aim of this study is to determine whether thromboxane inhibitors could attenuate the already established alcoholic liver injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Rats were fed<jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>t<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>and liquid diet for 6\u00a0weeks by intragastric infusion to induce liver injury after which EtOH was continued for 2 more weeks, and the rats were treated with either a thromboxane synthase inhibitor (<jats:styled-content style=\"fixed-case\">TXSI<\/jats:styled-content>) or a thromboxane receptor antagonist (<jats:styled-content style=\"fixed-case\">TXRA<\/jats:styled-content>). Liver pathology, lipid peroxidation, nuclear factor\u2010kappa\u2010<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>(<jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>\u2010\u03ba<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>) activity, tumor necrosis factor\u2010\u03b1 (<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1), cyclooxygenase\u20102 (<jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\u20102), and transforming growth factor\u2010beta1 (<jats:styled-content style=\"fixed-case\">TGF<\/jats:styled-content>\u2010\u03b2<jats:sub>1<\/jats:sub>) were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Administration of fish oil and<jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>t<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>caused fatty liver, necrosis, inflammation and fibrosis accompanied by increased in lipid peroxidation,<jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>\u2010\u03ba<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>activity, and expression of<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1,<jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\u20102, and<jats:styled-content style=\"fixed-case\">TGF<\/jats:styled-content>\u2010\u03b2<jats:sub>1<\/jats:sub>. Treatment with the thromboxane inhibitors ameliorated a certain level of the pathological and biochemical abnormalities. In particular,<jats:styled-content style=\"fixed-case\">TXSI<\/jats:styled-content>in addition to reducing necrosis, inflammation and fibrosis also decrease the severity of fatty liver.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Thromboxane inhibitors attenuated the alcoholic liver injury, inflammation and fibrotic changes despite continued<jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>t<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>administration. Inhibition of the production of thromboxane by thromboxane inhibitor and receptor antagonists may be a useful treatment strategy in clinical alcoholic liver disease.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1530-0277.2012.01838.x","type":"journal-article","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T15:37:44Z","timestamp":1339083464000},"page":"31-39","source":"Crossref","is-referenced-by-count":16,"title":["Thromboxane Inhibitors Attenuate Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administrations"],"prefix":"10.1111","volume":"37","author":[{"given":"Amin A.","family":"Nanji","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Dalhousie University School of Medicine Halifax NS Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Liong","sequence":"additional","affiliation":[{"name":"Department of Anatomy Li Ka Shing Faculty of Medicine University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Anatomy Li Ka Shing Faculty of Medicine University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Tipoe","sequence":"additional","affiliation":[{"name":"Department of Anatomy Li Ka Shing Faculty of Medicine University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1985.tb08920.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81694-3"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1515\/bc.2010.137"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1139\/y59-099"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00128.2002"},{"key":"e_1_2_6_7_1","first-page":"893","article-title":"Oxidative stress, isoprostanes and hepatic fibrosis","volume":"24","author":"Comporti M","year":"2009","journal-title":"Histol Histopathol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000046892"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00098.2006"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000078614.44983.97"},{"key":"e_1_2_6_11_1","first-page":"4","article-title":"Eicosanoids: potential regulators of extracellular matrix formation in the kidney","volume":"120","author":"Kohan DE","year":"1992","journal-title":"J Lab Clin Med"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2004.07.008"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220522"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.03.007"},{"key":"e_1_2_6_15_1","first-page":"209","article-title":"The epidemiology of alcoholic liver disease","volume":"27","author":"Mann RE","year":"2003","journal-title":"Alcohol Res Health"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i37.4960"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5584"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210620"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206776055985"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300402"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70236-1"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-3565(25)38874-9","article-title":"Plasma levels of a novel noncyclooxygenase\u2010derived prostanoid (8\u2010isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease","volume":"269","author":"Nanji AA","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260112"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.44.3.335"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6869"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3565(25)10178-X","article-title":"Pharmacological profile of BMS 180,291: a potent, long\u2010acting, orally active thromboxane A2\/prostaglandin endoperoxide receptor antagonist","volume":"264","author":"Ogletree ML","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(01)00411-8"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(84)05043-6"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60746-7"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2000.tb04615.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.22.13605"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2001.tb00058.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70374-X"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13271"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-008-8091-0"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1998.275.4.G605"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04202.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840060503"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.140.8.801"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2012.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2012.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T01:03:34Z","timestamp":1743296614000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2012.01838.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/j.1530-0277.2012.01838.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2012.01838.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,7]]}}}